纳指生物科技ETF(513290)
动态评分： 5.70分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2022-12-31 | DAWN | Day One Biopharmaceuticals Holding Co LLC | 11.2 | 0.15% |
| 2022-12-31 | RYTM | Rhythm Pharmaceuticals Inc | 11.6 | 0.15% |
| 2022-12-31 | SWTX | SpringWorks Therapeutics Inc | 11.48 | 0.15% |
| 2022-12-31 | VRNA | 维罗纳制药 | 11.23 | 0.15% |
| 2022-12-31 | XNCR | Xencor Inc | 11.04 | 0.15% |
| 2022-12-31 | AGIO | Agios Pharmaceuticals Inc | 10.91 | 0.14% |
| 2022-12-31 | DICE | DICE Therapeutics Inc | 10.52 | 0.14% |
| 2022-12-31 | FGEN | FibroGen Inc | 10.66 | 0.14% |
| 2022-12-31 | IMCR | Immunocore Holdings plc ADR | 10.41 | 0.14% |
| 2022-12-31 | NUVL | Nuvalent Inc-A | 10.74 | 0.14% |
| 2022-12-31 | RCKT | Rocket Pharmaceuticals Inc | 10.48 | 0.14% |
| 2022-12-31 | RVNC | Revance Therapeutics Inc | 10.75 | 0.14% |
| 2022-12-31 | SNDX | Syndax Pharmaceuticals Inc | 10.85 | 0.14% |
| 2022-12-31 | ACLX | Arcellx Inc | 9.6 | 0.13% |
| 2022-12-31 | AMPH | Amphastar Pharmaceuticals Inc | 9.58 | 0.13% |
| 2022-12-31 | KYMR | Kymera Therapeutics Inc | 9.68 | 0.13% |
| 2022-12-31 | MNKD | 曼恩凯德生物医疗 | 9.81 | 0.13% |
| 2022-12-31 | REPL | Replimune Group Inc | 9.57 | 0.13% |
| 2022-12-31 | RXRX | Recursion Pharmaceuticals Inc-A | 9.91 | 0.13% |
| 2022-12-31 | TVTX | Travere Therapeutics Inc | 9.55 | 0.13% |
公告&资料
